Biotech / Pharma View all members Browse by Membership Category
3D PARS is a virtual launch pad that provide product driven consultation support to a variety of industries including biotech/pharma. 3D PARS work with core facilities for fast track product development and prototyping efforts.
Aedicell® is a regenerative medicine company that has developed a unique proprietary process to transform human tissue into biologics for therapy, focusing on the conversion of human placenta into two skin substitute products, Plurivest® and Dermavest®. The company’s mission is to deliver wound therapies for superior outcomes at a lower cost to the healthcare system by using rapid, advanced product development and manufacturing techniques.
CNYBAC incubates and accelerates university-industry partnerships that discover, design, develop, and deploy innovative products for the bioscience marketplace.
ConSynance is a clinical-stage drug development company. We are committed to developing novel therapeutic solutions for unmet medical needs. Our pipeline includes innovative treatments for nonalcoholic steatohepatitis (NASH), the orphan disease Prader-Willi syndrome (PWS), and irritable bowel syndrome (IBS).
Efferent Labs is a preclinical-stage company focused on implantable biosensors. Its CytoComm™ Living Biosensor System uses living cells; a powerful tool to study life processes, to assess cellular function and biological signaling in vivo. The system transmits patient-specific data to the cloud, where it accessible in real-time by clinicians and researchers.
EndoGlow designs and distributes a line of medical devices that integrates Tissue Reveal Technology™ into surgical and medical procedures. Tissue Reveal Technology™ allows the medical team to visualize critical anatomy, appraise relative tissue depth and evaluate subsurface pathology. EndoGlow’s medical devices fluoresce under near infrared imaging which provides enhanced visualization and medical efficiency when it is most needed.
Ichor Therapeutics, Inc. is a biotechnology company and pre-clinical contract research organization headquartered in LaFayette, NY. The company operates two research programs which broadly focus on cancer and eye disease. Ichor also performs contract research for corporations, non-profit organizations, government agencies, and high net worth individuals.
Integrated Tissue Dynamics, LLC (INTiDYN) provides the biopharmaceutical industy novel and proprietary solutions for complex endpoint evaluations in clinical and research tissues. Particularly focused on skin, INTiDYN research aims to produce novel solutions to numerous debilitating human conditions, including chronic pain, diabetes, immuno- and dermato-pathologies, and trauma.
Caring for the world, one person at time, inspires and unites the people of Johnson & Johnson. They embrace innovation - bringing ideas, products and services to life to advance the health and well-being of people around the world. They believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better. Johnson & Johnson has over 125,000 employess in 60 countries and they are united in a common mission: to help people everywhere live longer, healthier, happier lives.
Kinentia Biosciences was founded in 2007 to utilize its platform chemoinformatics technology called Deep Data Mining (DDM™) to aid our clients in the discovery and development of novel pharmaceutical agents. DDM recognizes key risk factors involved in the drug discovery process and has built in process checks to mitigate this risk. Their team of consultants has extensive experience in the areas of global CRO and CMO management and materials procurement. By combining these capabilities with their platform technology Kinentia can greatly facilitate and mitigate the risk associated with pharmaceutical development.
Since 2002, Rochester, N.Y.-based Lumetrics has been developing and manufacturing high-precision thickness measurement and gauging systems for a growing cross-section of customers, including Fortune 500 companies in the medical, pharmaceutical, food packaging, eye-care products and coatings industries. Their original product line, OptiGauge, was launched through licensing of thin film measurement technology from Eastman Kodak. They've since expanded the OptiGauge series and developed other product lines to meet a more diverse range of industry needs.
The Neural Stem Cell Institute (NSCI) is dedicated to developing regenerative stem cell therapies for various diseases of the central nervous system (CNS): the brain, spinal cord and retina, regardless of the cause of injury. Led by MacArthur “Genius” Award winner Dr. Sally Temple who helped discover and define nervous system stem cells, NSCI is the first independent, non-profit stem cell research institute in the USA.
NextCorps is a group of entrepreneurs, advisors, venture capitalists and staff committed to creating the next generation of world-changing Rochester technology companies. Headquartered in iconic Sibley Square, NextCorps provides a space designed for collaboration and “creative collisions” along with the meeting, lab and fabrication resources that your startup will need to thrive.
Diagnostic technology platform - primary markets served: business to business tier one players
Pharmaceutical manufacturing/quality monitoring
PharmAdva, a start-up headquartered in Rochester, NY is the manufacturer and producer of the MedaCube, a automated home medication dispenser. Built, designed and forged to solve the $3 billion dollar healthcare issue of non-compliance of medication. The MedaCube provides consumers with an all in one solution to managing even the most difficult medication regiment.
Pharmaceutical, skin diseases
Precision Scientific Instruments Inc. (PSi™), a Delaware C-Corporation, is the sole manufacturer of the patented PSi1℠ system. PSi’s breakthrough metrology measurement system can reliably study sub-nano materials with up to 50 times greater resolution than the current Atomic Force and Scanning Tunneling Microscopes. This proprietary technology will enable scientists working with corporations, universities, medical research centers, government contractors and commercial manufacturers to study and develop cutting-edge materials used to miniaturize high-demand, high-profit products such as semiconductors, medical devices and hardware for the space and defense industry.
Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.
Their evolutionary advancements in brain health assessment, autism and Parkinson’s detection, will have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, one of these key technologies, ClearEdge, is currently available in the market and the others are slated for a 2018 release.
At Regeneron employees work every day to bring innovative thinking to the challenge of discovering and developing new medicines. Regeneron’s pursuit has one singular intent: to improve therapeutic outcomes for patients.
Repair Biotechnologies is a biotechnology company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself.
StemCultures is led by a team of dedicated cell biologists, industry technologists and entrepreneurs who are committed to working together to advance life science research. They create, manufacture and distribute reliable reagents that improve the experience of scientists with diverse interests and fields. Their proprietary controlled-release reagents provide a stable micro-environment for improved cell growth.
StemCultures is in partnership with the Neural Stem Cell Institute which possesses decades of research experience, including the lab of Dr. Sally Temple, co-founder of StemCultures, a pioneer credited with discovering stem like cells in the brain in 1989.
The UAlbany Office for Innovation Development and Commercialization helps members of the UAlbany community – faculty, staff and students – increase their impact on society by assisting in:
- Identifying innovations emerging from their research, teaching and service activities that could have broader societal impact;
- Assessing the costs and benefits associated with development and commercialization of the innovation;
- For innovations whose projected benefits exceed projected costs:
- Protecting the intellectual property as appropriate by patent, trademark, and/or copyright;
- Evaluating potential pathways and developing strategies for development and commercialization;
- Finding partners who can participate in further research, development and commercialization;
- Negotiating agreements that provide value to both partners while protecting the rights of U Albany participants and preserving intellectual property assets;
- Helping interested faculty, staff and students in their entrepreneurial pursuits.
Since 2005, Ultradian Diagnostics has been driven by an unmet need for high-quality, pain-free, wearable diagnostic devices capable of lowering costs and improving health care through superior accuracy and performance. Their management team is driven by a vision to provide users and clinicians with diagnostic tools to successfully monitor and manage chronic illnesses in a cost effective manner. Their focus is on developing a flexible device that minimizes sensor drift and signal noise.
An industry leader and innovator in infectious disease diagnostic development, ZeptoMetrix™ Corporation (ZMC) is a fully integrated biotechnology company with products and services that support all phases of Research & Development, Analytical and Diagnostic Studies, Assay Validation & Verification, Quality Control, Comparative Assay Performance Analysis, Service Testing, Manufacturing, BioStorage, Regulatory Submissions and Test Kit Commercialization.
Zetagen Therapeutics Inc., is an early stage regenerative medicine company that is creating bone regeneration solutions for a number of high volume clinical applications for use by orthopedic surgeons. Based on technology developed at SUNY-Upstate Medical University, Zetagen's product addresses the large unmet need for devices that promote safe and robust bone growth in the $4B bone regeneration market. The Zetagen bone regeneration device grows bone by activating a novel molecular pathway in mesenchymal stem cells. The serendipitous discovery of this pathway has led to the commercialization by Zetagen of the first-ever, small molecule-based osteo-inductive technology. As opposed to other products on the market that contain biologic growth
factors, which have declined in use precipitously due to high cancer risk and other side effects, Zetagen's solution is more effective at growing bone, has a unique safety profile, and is significantly less costly to manufacture.